Incumbents and Insurgents, sponsored by TowerBrook Capital Partners, is a candid series about the collision - and collaboration - between healthcare and technology. Hosted by Eric Larsen, President of the TowerBrook Healthcare Institute, the show explores how incumbent healthcare organizations are adopting AI, how tech insurgents are challenging entrenched models, and what it will take to improve outcomes while bending the cost curve.
Eric Jon Larsen serves as President, TowerBrook Advisors, and is a leading national expert on healthcare strategy and transformation. TowerBrook is a sector-based, focused investment firm seeking to deploy transformational capital and relevant industry insight to improve and grow businesses in the mid and upper mid-market space, across Europe and North America. The Firm primarily focuses on critical services within four sectors: business services, consumer products and services, financial services and healthcare. The Firm partners with and enables a constellation of major healthcare organizations including health systems, payers and other strategics. Underscoring its commitment to responsible business practices, TowerBrook is the first mainstream private equity firm in the world to be awarded B Corp certification.
Eric is a leading national healthcare strategist, author and advisor to CEOs and boards of directors of healthcare companies globally. For 25 years at the Advisory Board Company (the past five years as President, and now as President Emeritus), Eric dedicated himself to identifying and promulgating best practices to improve US and global healthcare. Since 1986 The Advisory Board Company, headquartered in Washington D.C., has served more than 4,500 healthcare organizations internationally developing proprietary research, technology and advisory services.
Following Optum's (UnitedHealth Group) acquisition of The Advisory Board In 2017, Eric’s purview expanded to include co-leading the formation and growth of Optum’s comprehensive health system partnerships as well as developing market strategy at UnitedHealth Group as Executive Vice President, Market Strategy.
Eric is active in healthcare venture capital, serving as Venture Partner to Thrive Capital ($20b AUM technology and healthcare investment firm) and SignalFire ($3b AUM VC focusing on early-stage seed through series B healthcare and technology companies).
Eric is a board member of R1 RCM and Fuze Health. He is honored to support Arianna Huffington as a board member of Thrive Global (www.thriveglobal.com). And he has also served on the boards of several digital health companies including Somatus (value-based kidney care); Contessa Health (hospital at home company, sold to Amedysis in 2021); and other AI health innovators.